Table 1 Summary of demographic and clinical data of healthy control and CRPS study cohorts
|  | Acute CRPS n = 19 | Chronic CRPS n = 6 | HC n = 25 |
|---|---|---|---|
Age (years) | 54 ± 9 | 40 ± 13* | 51 ± 11 |
Sex (female in %) | 74% | 100% | 80% |
CRPS type I | 58% (n = 11) | 83% (n = 5) |  |
Initially warm | 63% (n = 12) | 50% (n = 3) |  |
Time since event (months) | 5.2 ± 2.8 | 19.0 ± 4.8 |  |
Time since diagnosis (months) | 2.1 ± 2.5 | 7.3 ± 8.6 |  |
Mean pain (NRS) | 5.3 ± 2.2 | 5.0 ± 2.2 |  |
Max pain (NRS) | 7.4 ± 2.2 | 7.2 ± 3.0 |  |
Allodynia | 37% (n = 7) | 17% (n = 1) |  |
Hyperalgesia | 53% (n = 10) | 66% (n = 4) |  |
Oedema | 79% (n = 15) | 66% (n = 4) |  |
Skin temp (Δ°C) | -0.3 ± 1.4 | 0.5 ± 0.9 |  |
CSS1 | 10.4 ± 1.9 | 10.7 ± 2.1 |  |
NPSI2 | 30.4 ± 22.2 (n = 16) | 35.5 ± 28.1 | 3.2 ± 4.8 (n = 20) |
STAI-T3 | 45.0 ± 11.0 | 38.7 ± 17.3 | 31.7 ± 7.2 (n = 24) |
BDI-II4 | 14.6 ± 10.4 (n = 17) | 9.8 ± 9.5 | 3.9 ± 4 (n = 24) |
DASH5 | 62.4 ± 20.9 (n = 18) | 37.7 ± 23.1 | 3.5 ± 4.1 (n = 23) |